HIGHLIGHTS
- who: Richard B. Moss from the Department of Pediatrics, Stanford University School of Medicine, Welch Road, Suite , have published the research work: Severe Fungal Asthma: A Role for Biologics and Inhaled Antifungals, in the Journal: (JOURNAL)
- what: These results suggest this approach has some merit but probably insufficient impact to be widely adopted, particularly when side effects like bronchospasm associated with parenteral formulation are considered .
SUMMARY
Copyright: It is useful to situate the patient with allergic fungal airways disease within the larger context of fungal lung disease, with a particular focus . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.